Literature DB >> 2144843

Functional and phenotypic changes in human lymphocytes after coincubation with Leishmania donovani in vitro.

L Hviid1, A L Sørensen, A Kharazmi, T G Theander.   

Abstract

In this paper we describe functional and phenotypic changes in T cells after in vitro coincubation of peripheral blood mononuclear cells (PBMC) and Leishmania donovani parasites at different parasite/peripheral blood mononuclear cell ratios. The phytohemagglutinin (PHA)-induced lymphoproliferative response was reduced by the coincubation, and at the maximal parasite/peripheral blood mononuclear cell ratio used (7.5:1), the average response was less than 40% of the response in the absence of parasites. The cause of the reduction in lymphoproliferation is not clear, but it requires live parasites. Interleukin-1 production was unaffected, the levels of soluble interleukin-2 receptor in supernatants were not changed by the coincubation, and the addition of exogenous interleukin-2 failed to revert the suppressive effect of the parasites. In addition to the reduction in lymphocyte proliferation, phenotypic lymphocyte changes were observed. Cell surface expression of the CD3 antigen, which is part of the CD3-T-cell receptor complex, was significantly reduced with increasing parasite/peripheral blood mononuclear cell ratios; the reduction was general in the sense that the parasites caused a shift in the fluorescent intensities of anti-CD3 labeled cells toward lower values, without affecting the distribution pattern. In contrast, the parasites altered the CD25 (interleukin-2 receptor) expression on PHA-stimulated cells from a homogenous CD25-positive population to two populations, one small and without CD25 expression and the other, larger population with only a slight reduction in size and CD25 expression. In addition to the changes in expression of surface antigens, a general reduction in the size of PHA-stimulated lymphocytes after coincubation with the parasites was observed. The data presented thus suggest that the inhibition of the proliferative response to PHA by live L. donovani in vitro is associated with early processes in lymphocyte activation. Further studies on the inhibitory phenomena described may be of potential significance in the investigation of the suppressive mechanisms in human visceral leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144843      PMCID: PMC313633          DOI: 10.1128/iai.58.10.3163-3167.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Immunological features of kala-azar.

Authors:  H R Rezai; S M Ardehali; G Amirhakimi; A Kharazmi
Journal:  Am J Trop Med Hyg       Date:  1978-11       Impact factor: 2.345

2.  Capping of the surface OKT3 binding molecule prevents the T-cell proliferative response to antigens: evidence that this molecule conveys the activation signal.

Authors:  G M Kammer; R Kurrasch; J J Scillian
Journal:  Cell Immunol       Date:  1984-08       Impact factor: 4.868

3.  Action of leishmanial excreted factor (EF) on human lymphocyte blast transformation.

Authors:  M V Londner; S Frankenburg; G M Slutzky; C L Greenblatt
Journal:  Parasite Immunol       Date:  1983-05       Impact factor: 2.280

4.  Suppression of human lymphocyte responses by Trypanosoma cruzi.

Authors:  L A Beltz; F Kierszenbaum
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

5.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

6.  Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania.

Authors:  E M Carvalho; O A Bacellar; S Reed; A Barral; H Rocha
Journal:  Braz J Med Biol Res       Date:  1988       Impact factor: 2.590

7.  Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.

Authors:  L A Beltz; M B Sztein; F Kierszenbaum
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

8.  Interleukin 2 receptor in patients with localized and systemic parasitic diseases.

Authors:  O Josimovic-Alasevic; H Feldmeier; K Zwingenberger; G Harms; H Hahn; M Shrisuphanunt; T Diamantstein
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

9.  Parasite-monocyte interactions in human leishmaniasis: production of interleukin-1 in vitro.

Authors:  G D Crawford; D J Wyler; C A Dinarello
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

10.  Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

Authors:  E M Carvalho; O Bacellar; A Barral; R Badaro; W D Johnson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more
  5 in total

1.  CXCL10 production by human monocytes in response to Leishmania braziliensis infection.

Authors:  Diego A Vargas-Inchaustegui; Alison E Hogg; Gianfranco Tulliano; Alejandro Llanos-Cuentas; Jorge Arevalo; Janice J Endsley; Lynn Soong
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

2.  Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes.

Authors:  F Kierszenbaum; M B Sztein
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.

Authors:  M Kemp; J A Kurtzhals; K Bendtzen; L K Poulsen; M B Hansen; D K Koech; A Kharazmi; T G Theander
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

5.  Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.

Authors:  Rajan Guha; Shantanabha Das; June Ghosh; Shyam Sundar; Jean Claude Dujardin; Syamal Roy
Journal:  PLoS Negl Trop Dis       Date:  2014-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.